Influence of CYP3A5 and ABCB1 polymorphisms on the pharmacokinetics of vincristine in adult patients receiving CHOP therapy-Reference-Cited by-同舟云学术

Influence of CYP3A5 and ABCB1 polymorphisms on the pharmacokinetics of vincristine in adult patients receiving CHOP therapy

Published:2023-08-23 Issue:5 Volume:92 Page:391-398
ISSN:0344-5704
Container-title:Cancer Chemotherapy and Pharmacology
language:en
Short-container-title:Cancer Chemother Pharmacol

Author:

Nakagawa Junichi,Takahata Takenori,Chen Yu,Saito Kensuke,Kamata Kosuke,Tachita Takuto,Yamashita Satoru,Saito Keigo,Ueno Kayo,Sato Atsushi,Sakuraba Hirotake,Niioka Takenori^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Cancer Research,Pharmacology,Toxicology,Oncology

Link

https://link.springer.com/content/pdf/10.1007/s00280-023-04580-1.pdf

Reference25 articles.

1. Carozzi VA, Canta A, Chiorazzi A (2015) Chemotherapy-induced peripheral neuropathy: what do we know about mechanisms? Neurosci Lett 596:90–107. https://doi.org/10.1016/j.neulet.2014.10.014

2. Jordan MA, Wilson L (2004) Microtubules as a target for anticancer drugs. Nat Rev Cancer 4(4):253–265. https://doi.org/10.1038/nrc1317

3. Coiffier B, Lepage E, Briere J, Herbrecht R, Tilly H, Bouabdallah R et al (2002) CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma. N Engl J Med 346(4):235–242. https://doi.org/10.1056/NEJMoa011795

4. Haim N, Epelbaum R, Ben-Shahar M, Yarnitsky D, Simri W, Robinson E (1994) Full dose vincristine (without 2-mg dose limit) in the treatment of lymphomas. Cancer 73(10):2515–2519. https://doi.org/10.1002/1097-0142(19940515)73:10%3c2515::aid-cncr2820731011%3e3.0.co;2-g

5. Sethi VS, Jackson DV Jr, White DR, Richards F 2nd, Stuart JJ, Muss HB et al (1981) Pharmacokinetics of vincristine sulfate in adult cancer patients. Cancer Res 41(9 Pt 1):3551–3555